ESTRO 2026

Accuray
Symposium

Precision Radiotherapy in 2026:

Clinical Impact and Implementation

Saturday, May 16th from 13:00 to 14:00 CEST

Location: Hall C, Room T1

Chairmen:

Oscar Matzinger, Ph.D., M.D,

Chief Medical Officer, Swiss Medical Network, Clinique de Genolier, Genolier, Switzerland

Professor of Practice at ETH Zurich, Zurich, Switzerland

Seth Blacksburg, M.D., MBA,

Senior Vice President, Chief Medical Officer, Accuray

Adjunct Professor, NYU Langone Health, New-York, USA

Speakers:

Advancing Precision in Breast Radiotherapy: Hypofractionation, Workflow Reproducibility, and the Path Toward Non-Operative Management

Carlotta Becherini, M.D,
Radiation Oncologist, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

Stereotactic Ablative Radiotherapy for Renal Tumors: Current Practice and Outcomes

Shankar Silva, Ph.D., MBBS, FRANZCR
Professor, Radiation Oncologist, Peter MacCallum Cancer Centre, Australia

Precision Radiotherapy for Prostate Cancer: Stereotactic Approaches, Motion Control, and Practice Evolution

Sean Collins, M.D., Ph.D.​ 
Professor, Radiation Oncologist​, Vice Chair of Faculty Affairs, Radiation Oncology, University of South Florida​, USA

Pre-Register for our Symposium​

TIMESESSIONFACULTY
5 minWelcome
Seth Blacksburg, M.D. MBA SVP,
Chief Medical Officer,
Accuray

Alison Tree
Consultant Clinical Oncologist
MBBS BSc FRCR MD (Res)
The Royal Marsden NHS Foundation Trust, London, UK
12 minSBRT for Localized Prostate Cancer: Evidence, Techniques, and Future Directions
Nicholas van As, M.D.
Medical Director and Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust, and Professor in Precision Prostate Radiotherapy at The Institute of Cancer Research, London, UK
12 minAdvances in Reirradiation for Prostate Cancer: Pushing the Boundaries of Precision and Efficacy
Barbara Alicja Jereczek-Fossa, M.D., Ph.D.
Full Professor of Radiation Oncology, University of Milan, Italy. Head of the Department of Radiation Oncology, European Institute of Oncology, Milan, Italy
12 minEmerging Data on SBRT for Primary and Oligometastatic Kidney Cancer
Nadia di Muzio, M.D.
Director of Radiotherapy Department San Raffaele Scientific Institute, Milan, Italy
12 minAdjuvant Radiation Therapy in Bladder Cancer: Why, Who and How?
Vedang Murthy, M.D., DNB, DipEPP
Professor of Radiation Oncology, Tata Memorial Centre, Mumbai, India
7 minConcluding Remarks
Seth Blacksburg, M.D. MBA
SVP, Chief Medical Officer,
Accuray

Alison Tree
Consultant Clinical Oncologist
MBBS BSc FRCR MD (Res)
The Royal Marsden NHS Foundation Trust,
London, UK

Medical Affairs

Accuray Medical Affairs serves as your comprehensive resource hub for clinical evidence, and peer collaboration through our user community.

Services

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

Solutions

From robotic to helical radiation therapy delivery, we invent unique, market-changing solutions that are designed to deliver radiation treatments across a full spectrum of patient needs.

Treatment Centers

Radiosurgery

Adaptive Radiotherapy

Systems integration

What's New

Your go-to source for staying informed about our advancements.

Why Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.